Overview
Congenital brain dysgenesis due to glutamine synthetase deficiency is an extremely rare inherited metabolic disorder. It is also sometimes called glutamine synthetase deficiency or GS deficiency. The disease is caused by the body not making enough of an enzyme called glutamine synthetase. This enzyme is responsible for producing glutamine, one of the most important amino acids in the body. Without enough glutamine, the brain cannot develop properly before birth, and the nervous system is severely affected. Babies born with this condition typically have serious brain malformations that are present from birth. These include abnormal brain structure, very small brain size (microcephaly), and problems with the folds and layers of the brain. Because glutamine is critical for brain development and for controlling nerve signals, affected infants usually experience severe seizures that begin in the first days or weeks of life and are very difficult to control. Muscle tone is often very low, and babies may have trouble feeding and breathing. There is currently no cure for this condition. Treatment focuses on managing symptoms, especially seizures, and providing supportive care. Some research has explored whether giving glutamine supplements could help, but results have been limited. The overall outlook is very serious, and most affected children have profound developmental challenges. Early diagnosis through genetic testing is important for families to understand the condition and plan care.
Key symptoms:
Severe seizures starting in the first days or weeks of lifeAbnormal brain structure present from birth (brain malformations)Very small head size (microcephaly)Very low muscle tone (floppy baby)Profound intellectual disabilityDifficulty feedingBreathing problemsLittle or no developmental progressAbnormal eye movementsIrritability or unusual behavior in newborns
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital brain dysgenesis due to glutamine synthetase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital brain dysgenesis due to glutamine synthetase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Congenital brain dysgenesis due to glutamine synthetase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital brain dysgenesis due to glutamine synthetase deficiency.
Community
No community posts yet. Be the first to share your experience with Congenital brain dysgenesis due to glutamine synthetase deficiency.
Start the conversation →Latest news about Congenital brain dysgenesis due to glutamine synthetase deficiency
No recent news articles for Congenital brain dysgenesis due to glutamine synthetase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific brain malformations does my child have, and what do they mean for their development?,Which anti-seizure medications are most likely to help, and what should I do if a seizure does not stop?,Should we try glutamine supplementation, and what evidence exists for it in this condition?,What therapies (physical, occupational, speech) would benefit my child most right now?,Are there any clinical trials or research studies we could consider joining?,What should we expect over the next months to years, and how do we plan for future care needs?,Should other family members be tested as carriers, and what are the chances of this happening in a future pregnancy?
Common questions about Congenital brain dysgenesis due to glutamine synthetase deficiency
What is Congenital brain dysgenesis due to glutamine synthetase deficiency?
Congenital brain dysgenesis due to glutamine synthetase deficiency is an extremely rare inherited metabolic disorder. It is also sometimes called glutamine synthetase deficiency or GS deficiency. The disease is caused by the body not making enough of an enzyme called glutamine synthetase. This enzyme is responsible for producing glutamine, one of the most important amino acids in the body. Without enough glutamine, the brain cannot develop properly before birth, and the nervous system is severely affected. Babies born with this condition typically have serious brain malformations that are pre
How is Congenital brain dysgenesis due to glutamine synthetase deficiency inherited?
Congenital brain dysgenesis due to glutamine synthetase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital brain dysgenesis due to glutamine synthetase deficiency typically begin?
Typical onset of Congenital brain dysgenesis due to glutamine synthetase deficiency is neonatal. Age of onset can vary across affected individuals.